Exacerbations Down in Asthma Patients on GLP-1R Agonists for T2D

MONDAY, June 14, 2021 -- For adults with type 2 diabetes and asthma, exacerbation rates are lower for those prescribed glucagon-like peptide-1 receptor (GLP-1R) agonists, according to a study recently published in the American Journal of Respiratory...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news